Vanda Pharmaceuticals Inc.
VNDA
$4.99
$0.071.42%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.91M | -5.32M | -4.52M | -4.15M | -2.40M |
| Total Depreciation and Amortization | 1.97M | 1.97M | 1.97M | 2.22M | 1.16M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 404.00K | -1.58M | 235.00K | 2.51M | -5.31M |
| Change in Net Operating Assets | 718.00K | -9.64M | -4.61M | 6.98M | 2.82M |
| Cash from Operations | -1.82M | -14.58M | -6.93M | 7.57M | -3.73M |
| Capital Expenditure | -214.00K | -161.00K | -1.63M | -2.71M | -100.92M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.21M | 12.22M | -13.63M | -15.51M | 57.14M |
| Cash from Investing | 3.99M | 12.06M | -15.26M | -18.22M | -43.78M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -155.00K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -155.00K | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -202.00K | 68.00K | -15.00K | -14.00K | 150.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.82M | -2.46M | -22.21M | -10.66M | -47.37M |
